Shelton Capital Management’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,270
Closed -$215K 717
2022
Q1
$215K Hold
5,270
0.01% 746
2021
Q4
$252K Hold
5,270
0.01% 659
2021
Q3
$218K Hold
5,270
0.01% 726
2021
Q2
$238K Hold
5,270
0.01% 685
2021
Q1
$233K Buy
+5,270
New +$199K 0.01% 679
2018
Q4
Sell
-6,631
Closed -$261K 783
2018
Q3
$261K Buy
+6,631
New +$299K 0.01% 694

Other funds holding ADNT

Shelton Capital Management's ADNT Position: Q2 2022 in Review

Shelton Capital Management sold out of Adient (ADNT) in Q2 2022, closing a stake of 5,270 shares — an estimated $215K sold.

Shelton Capital Management first reported a position in ADNT in Q3 2018 and held it in 6 quarters. The position peaked at $261K in Q3 2018. 258 funds tracked by Wall St. Rank hold ADNT as of Q2 2022.

  • Shelton Capital Management reported no remaining Adient position as of Q2 2022 after selling out during the quarter.
  • Shelton Capital Management sold 5,270 Adient shares in Q2 2022, an estimated $215K.
  • Shelton Capital Management first reported a position in Adient in Q3 2018 and held it in 6 quarters.
  • Shelton Capital Management's Adient position peaked at $261K in Q3 2018.
  • 258 funds tracked by Wall St. Rank held Adient as of Q2 2022.

Based on Shelton Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.